MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy |
| |
Authors: | Takeda Kazuna Kanao Shotaro Okada Tomohisa Ueno Takayuki Toi Masakazu Ishiguro Hiroshi Mikami Yoshiki Tanaka Shiro Togashi Kaori |
| |
Institution: | Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawaharacho, Sakyoku, Kyoto 606-8507, Japan. |
| |
Abstract: | AimTo investigate if there is any difference in evaluation of residual tumor size after neoadjuvant chemotherapy (NAC) and neoadjuvant endocrine therapy (NAE).MethodsSeventy-eight tumors in 57 patients were prospectively enrolled. Residual tumor sizes in contrast-enhanced MRI after NAC and NAE were compared with those measured on surgical specimen by using linear regression analyses. The line slope values >1 indicates overestimation by MRI. Differences in types of shrinkage patterns: concentric shrinkage (CS) and dendritic shrinkage (DS) were also investigated.ResultsFifty lesions were treated with NAC and 28 lesions were treated with NAE. Shrinkage patterns were CS in 33 lesions and in 45 lesions. The slopes values were 0.75 (R = 0.92) and 0.70 (R = 0.90) for NAC and NAE, respectively, and no significant difference was observed (p = 0.46). However, they were 1.02 (R = 0.92) and 0.68 (R = 0.92), respectively for CS and DS with significant difference (p < 0.01). The difference between CS and DS was found only in a subgroup with size by MRI >20 mm.ConclusionContrast enhanced MRI enabled fairly accurate measurement in NAE as well as in NAC. |
| |
Keywords: | MRI Breast cancer Neoadjuvant endocrine therapy Neoadjuvant chemotherapy Residual tumor size |
本文献已被 ScienceDirect PubMed 等数据库收录! |